hengrui glp 1 BMS signs $15.2bn R&D alliance with China's Jiangsu Hengrui Pharmaceuticals at ADA

Numerous analysts have said the GLP-1s are very likely to disrupt certain areas of the MedTech industry, while others say MedTech can live side-by-side with the weight-loss drugs.1 In fact, the impact of GLP-1s is likely to be more nuanced than the blunt conclusions drawn by market watchers, with some companies and segments affected more than others

Gastric inhibitory polypeptide (GIP) and glucagonlike peptide1 (GLP1) are the two primary incretin hormones secreted from the intestine on ingestion of glucose or nutrients to stimulate insulin secretion from pancreatic cells

Nekter Juice Bar is at the forefront of the juice cleanse revolution with cold-pressed juices, smoothies and acai bowl

A new study explores the interactions between cosmetic Botox and GLP-1 weight loss medications and whether it impacts how long botox results last

1. Cleanse

Explore our recent survey findings showing physicians' growing concerns on GLP-1 overprescribing, long-term sustainability, and the future of obesity treatment.